key: cord-0708011-jokxik83 authors: Buggs-Saxton, Colleen title: Care of Pediatric Patients with Diabetes during the COVID-19 Pandemic date: 2021-05-21 journal: Pediatr Clin North Am DOI: 10.1016/j.pcl.2021.05.014 sha: 4c825c2f767605db8c2e9f2e9fc90e4d448dd324 doc_id: 708011 cord_uid: jokxik83 This article summarizes clinical observations and management strategies in pediatric type 1 diabetes (T1D) during the COVID-19 pandemic. Despite initial fears that children with diabetes would, similar to adults with diabetes, be at risk for severe COVID-19, the majority of pediatric patients with a history of type 1 diabetes (T1D) who developed COVID-19 had mild disease or were asymptomatic similar to their peers without diabetes. Studies found that pediatric patients with new-onset diabetes often presented with more severe diabetic ketoacidosis (DKA) in part due to both parental anxiety with seeking emergency medical care and systemic barriers to accessing health care during a pandemic. The article also summarizes the use of telemedicine to provide ongoing care for pediatric patients with T1D during the COVID-19 pandemic. Finally, the article highlights important lessons learned about management of pediatric diabetes during the COVID-19 pandemic. presented with more severe diabetic ketoacidosis (DKA) 2. The majority of pediatric patients with type 1 diabetes (T1D) who developed COVID-19 had mild disease or were asymptomatic similar to children without diabetes. 3. Stay at home initiatives and school closures often resulted in improved glycemic control for children with diabetes secondary to closer parental monitoring. 4. Improve telemedicine adaptations for pediatric diabetic teams will likely continue to support care for these children after the pandemic. Provide a brief summary of your article (100 to 150 words; no references or figures/tables). The synopsis appears only in the table of contents and is often used by indexing services such as PubMed This article summarizes clinical observations and management strategies in pediatric type 1 diabetes (T1D) during the COVID-19 pandemic. Despite initial fears that children with diabetes would, similar to adults with diabetes, be at risk for severe COVID-19, the majority of pediatric patients with a history of type 1 diabetes (T1D) who developed COVID-19 had mild disease or were asymptomatic similar to their peers without diabetes. Studies found that pediatric patients with new-onset diabetes often presented with more severe diabetic ketoacidosis (DKA) in part due to both parental anxiety with seeking emergency medical care and systemic barriers to accessing health care during a pandemic. The article also summarizes the use of telemedicine to provide ongoing care for pediatric patients with T1D during the COVID-19 pandemic. Finally, the article highlights important lessons learned about management of pediatric diabetes during the COVID-19 pandemic. 1. The Coronavirus Disease 2019 (COVID- 19) , which is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), created a pandemic in March 2020 with now more than 120 million cases and over 2. 5 (Ebekozien, Noor et al. 2020 ). In this group of patients, the mean age was 24.8 years with the youngest age 7 years, and most patients had hyperglycemia and mild symptoms including fever, cough, fatigue, and shortness of breath. The most common comorbidities among these patients were obesity and hypertension/cardiovascular, and one death was reported in a patient with DKA. Overall, the study concluded that children and adolescents with T1D and COVID-19 had a similar disease course as other children with COVID-19 who did not have diabetes. Taken together, these studies show that the majority of pediatric patients with T1D do not become severely ill with COVID-19, unlike adults with diabetes and COVID-19. Although the clinical course among pediatric patients already diagnosed with diabetes and COVID-19 was not as severe as expected, some reports examined whether COVID-J o u r n a l P r e -p r o o f 19 had any impact on the initial diagnosis of T1 in pediatric patients. It is well known that there is a seasonal variation associated with new onset T1D with increased cases during the fall and winter when exposure to viruses increase. 13 pandemic persisted and became more evident among patients with COVID-19. Although the study highlights the need to provide more targeted approach to vulnerable patients with T1D, no new insights were identified to that could be immediately implemented especially during the pandemic. pandemic, but many clinics did not report any significant morbidity among their Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -A systematic review, metaanalysis, and meta-regression Factors associated with COVID-19-related death using OpenSAFELY Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study COVID-19 in people with diabetes: understanding the reasons for worse outcomes COVID-19 and Type 1 Diabetes: Concerns and Challenges Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19? Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19 Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S Environmental triggers and determinants of type 1 diabetes Viruses and type 1 diabetes: a new look at an old story Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children? Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region Unintended Consequences of Coronavirus Disease-2019: Remember General Pediatrics Changing admission patterns in paediatric emergency departments during the COVID-19 pandemic New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K COVID-19, diabetes mellitus and ACE2: The conundrum Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany? Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units Pediatric Intensive Care Unit Admissions for COVID-19: Insights Using State-Level Data The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities Disparities in Vulnerability to Severe Complications from COVID-19 in the United States Full Inequities in Diabetic Ketoacidosis among Patients with Type 1 diabetes and COVID-19: Data from 52 US Clinical Centers Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID-19 global pandemic Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit -what have we learned from the COVID-19 lockdown? Paediatric diabetes care during the COVID-19 pandemic: Lessons learned in scaling up telemedicine services